Bavarian Nordic Logo

Bavarian Nordic

A biotech firm developing and manufacturing life-saving vaccines for travel and public health.

BAVA | CO

Overview

Corporate Details

ISIN(s):
DK0015998017 (+1 more)
LEI:
2138006JCDVYIN6INP51
Country:
Denmark
Address:
PHILIP HEYMANS ALLE 3, 2900 HELLERUP
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bavarian Nordic is a fully integrated biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The company specializes in preventing infectious diseases through innovative vaccine technologies. It serves as a leading global provider of travel vaccines and is a key partner for governments and international organizations in delivering public health solutions. Bavarian Nordic manages the entire product lifecycle, from initial research and development through to large-scale manufacturing and distribution.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-31 15:56
Major Shareholding Notification
English 188.4 KB
2025-10-31 15:56
Major Shareholding Notification
Danish 112.4 KB
2025-10-31 15:56
Major Shareholding Notification
English 2.9 KB
2025-10-31 15:56
Major Shareholding Notification
Danish 2.8 KB
2025-10-31 14:07
M&A Activity
English 148.1 KB
2025-10-31 14:07
M&A Activity
Danish 19.9 KB
2025-10-31 14:07
M&A Activity
English 158.1 KB
2025-10-31 14:07
M&A Activity
Danish 173.8 KB
2025-10-31 14:07
M&A Activity
English 19.2 KB
2025-10-31 14:07
M&A Activity
Danish 136.4 KB
2025-10-31 09:14
Regulatory News Service
English 7.7 KB
2025-10-31 09:14
Regulatory News Service
Danish 7.0 KB
2025-10-31 09:14
Regulatory News Service
Danish 185.5 KB
2025-10-31 09:14
Regulatory News Service
English 167.0 KB
2025-10-29 13:29
Major Shareholding Notification
Danish 112.2 KB

Automate Your Workflow. Get a real-time feed of all Bavarian Nordic filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bavarian Nordic

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bavarian Nordic via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Develops molecular diagnostics using DNA methylation biomarkers for early cancer detection.
South Korea 228760
Genomtec S.A. Logo
Develops a mobile platform for rapid, precise genetic diagnostics at the point-of-care.
Poland GMT
GENOTECH CORP. Logo
A biotech firm offering gene synthesis, genome analysis, and biopharmaceutical products globally.
South Korea 066830
Genprex, Inc. Logo
A clinical-stage firm developing non-viral gene therapies for cancer and diabetes.
United States of America GNPX
Gentian Diagnostics ASA Logo
Develops & manufactures IVD immunoassays for human & veterinary disease diagnostics.
Norway GENT
GERON CORP Logo
Commercializes an approved, first-in-class telomerase inhibitor for blood cancers.
United States of America GERN
GH Research PLC Logo
Clinical-stage biopharma developing mebufotenin therapies for psychiatric disorders.
United States of America GHRS
GI Innovation Inc. Logo
Develops fusion protein biologics for oncology, allergic, and metabolic diseases.
South Korea 358570
GILEAD SCIENCES, INC. Logo
Develops innovative medicines for life-threatening diseases in virology, oncology & inflammation.
United States of America GILD
GlaxoSmithKline PLC Logo
A biopharmaceutical company developing vaccines and specialty medicines to prevent and treat disease.
United Kingdom GSK

Talk to a Data Expert

Have a question? We'll get back to you promptly.